Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France

BMC Health Serv Res. 2018 Jan 4;18(1):3. doi: 10.1186/s12913-017-2802-2.

Abstract

Background: To investigate the relationship between hospital volume activities and the survival for Epithelial Ovarian Carcinoma (EOC) patients in France.

Methods: This retrospective study using prospectively implemented databases was conducted on an exhaustive cohort of 267 patients undergoing first-line therapy during 2012 in the Rhone-Alpes Region of France. We compared Progression-Free Survival for Epithelial Ovarian Carcinoma patients receiving first-line therapy in high- (i.e. ≥ 12 cases/year) vs. low-volume hospitals. To control for selection bias, multivariate analysis and propensity scores were used. An adjusted Kaplan-Meier estimator and a univariate Cox model weighted by the propensity score were applied.

Results: Patients treated in the low-volume hospitals had a probability of relapse (including death) that was almost two times (i.e. 1.94) higher than for patients treated in the high-volume hospitals (p < 0.001).

Conclusion: To our knowledge, this is the first study conducted in this setting in France. As reported in other countries, there was a significant positive association between greater volume of hospital care for EOC and patient survival. Other factors may also be important such as the quality of the surgical resection.

Keywords: Centralization of care; Disease management program; Epithelial ovarian cancer; France; Propensity score.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma, Ovarian Epithelial
  • Databases, Factual
  • Disease-Free Survival
  • Female
  • France
  • Hospitals / statistics & numerical data*
  • Humans
  • Middle Aged
  • Neoplasms, Glandular and Epithelial / therapy*
  • Ovarian Neoplasms / therapy*
  • Retrospective Studies
  • Treatment Outcome